Barry Greenberg has been involved in Alzheimer’s disease research and drug discovery since 1985. He is currently Director of Neuroscience Drug Discovery and Development at the University Health Network and Strategy Director of the Toronto Dementia Research Alliance, a consortium involving academic research and five memory clinics at hospitals affiliated with the University of Toronto. Dr. Greenberg helped draft the scientific recommendations for the National Alzheimer’s Project Act (NAPA) in the U.S. in 2012, and chaired the Executive Committee for the Alzheimer’s Research Summit at the National Institute on Ageing (NIA) in February 2015. He was recently appointed by the NIA to chair an international committee to strategize the structure of the Alzheimer’s Research Center network in the U.S. contribute to achieving the goals of the US National Plan on dementia. He has authored or co-authored over 70 articles in peer-reviewed journals and 19 book chapters and reviews.
